Annual result: details
in CHF
2024
2023
ASSETS
Liquid assets
2'616'045
1'790'998
Securities
23'501'590
24'193'709
Accounts receivable
2'340'302
2'133'897
Other current receivables
137'283
133'908
Accruals
350'671
646'485
Current assets
28'945'891
28'898'997
Financial assets
155'359
155'032
Tangible assets
646'757
811'232
Intangible fixed assets
1'839'339
1'177'970
Fixed assets
2'641'455
2'144'234
ASSETS
31'587'346
31'043'231
LIABILITIES
Accounts payable
1'262'226
1'236'214
Other current liabilities
760'609
1'171'750
Deferrals
2'946'075
1'532'992
Short-term liabilities
4'968'910
3'940'956
Long-term provisions
1'034'789
1'034'789
Fund capital
9'856'990
11'991'440
Long-term liabilities
10'891'779
13'026'229
Capital stock
2'000'000
2'000'000
Statutory retained earnings
840'130
840'130
Committed capital
12'470'767
10'908'267
Unrestricted capital
327'649
299'213
Annual result
88'111
28'436
Equity capital-Organisational capital
15'726'657
14'076'046
LIABILITIES
31'587'346
31'043'231
Statement of accounts at 31 December 2024
in CHF
2024
2023
Income from donations, other contributions
1'859'688
1'790'189
Income from public remit
1'889'867
1'677'641
Income from donor searches and transplants
16'279'725
15'120'212
Income from services
1'162'405
1'078'817
Income from project contributions of charitable organisations,
non-profit organisations
289'524
1'553'609
Operating income
21'481'209
21'220'468
Expenditure on national assigned duties
-6'110
-7'086
Cost of donor recruitment and care
-541'898
-385'569
Cost of donor searches and transplants
-9'734'717
-8'146'052
Expenditure materials and services
-1'970'723
-1'438'998
Staff costs
-6'914'124
-6'687'912
Other operating result
-1'856'990
-2'046'430
Expenditure – administration, consulting, and IT
-2'121'277
-1'747'290
Depreciation
-536'446
-331'441
Total operating expenditure
-23'682'285
-20'790'778
Operating result
-2'201'076
429'690
Financial expense
-401'823
-542'126
Financial income
2'119'060
1'309'538
Net financial income
1'717'237
767'412
Annual result before change in fund capital
-483'839
1'197'102
Transfer to fund capital
-3'245'036
-4'357'033
Use of fund capital
5'379'486
3'728'935
Annual result before change in capital of the organisation
1'650'611
569'004
Appropriation of earnings
Change in organisational capital
-1'562'500
-540'568
Annual result
88'111
28'436
Solidarity fund
In 2024, the fund paid out a total of CHF 503,400. These payments helped to ease the difficult financial situations of 26 HIV patients, or their families, and of 2 people infected with hepatitis. The SRC Humanitarian Foundation’s contributions to the fund are currently being suspended in order to reduce the accumulated capital.
Solidarity fund Blood
The solidarity fund Blood was set up by the Swiss Red Cross in 1993. The payments from this fund are intended to ease the suffering of people who have been infected with dangerous diseases through blood products. The large majority of these patients were infected with HIV or hepatitis C in the 1980s or early 1990s. Through this fund, which was set up specifically for this purpose, the Swiss Red Cross pays tribute to the solidarity felt for people harmed by blood products received via transfusions. Payment of benefits from the fund is a voluntary undertaking, as neither Swiss Transfusion SRC nor the Swiss Red Cross can be held responsible for the residual risk associated with blood products.
In 2023, the Red Cross Council and the SRC Humanitarian Foundation approved the indefinite continuance of the payments into the solidarity fund for the benefit of the 28 people.
Statement of solidarity fund Blood 2024
in CHF
2024
2023
Accounts
503'400
494'400
Staff costs
12'322
18'400
Material expenditure
34'642
32'561
Total expenditure
550'364
545'361
SRC Humanitarian Foundation
0
650'000
Additional revenue
9'000
9'000
Total income
9'000
659'000
Result
-541'364
113'639
Financial position at 31.12.
Assets 1.1.
2'714'637
2'600'998
Result
-541'364
113'639
Assets 31.12.
2'173'272
2'714'637